QS Centre for Neuromuscular Diseases News

Congratulations to Professor Mary Reilly, a globally renowned and award-winning clinical neurologist, who has been awarded an honorary MBE for her services to medicine.

Published in Lancet Neurology, UCL researchers have delivered a ground- breaking investigator-led head-to-head rare disease trial that will impact clinical practice globally.

Congratulations to Professor Mary Reilly (Neuromuscular Diseases, UCL Queen Square Institute of Neurology) who was been awarded the prestigious Alan J. Gebhart Prize for Excellence in Peripheral Nerve Research at the Peripheral Nerve Society In Montreal in June 2024.

A new research centre co-led by UCL scientists in the Faculty of Brain Sciences will help thousands of people living with mitochondrial diseases to get access to improved diagnostics and treatments.

The Academy has today announced that Professor Michael Hanna FMedSci, Professor of Clinical Neurology and Director of both the UCL Queen Square Institute of Neurology and UCL MRC International Centre for Genomic Medicine in Neuromuscular Diseases, has been appointed Treasurer.

Professor Mary Reilly (UCL Queen Square Institute of Neurology) was interviewed with Christopher Samuel (artist and patient at the National Hospital for Neurology and Neurosurgery) by BBC London news at the launch of the A Letter in Mind exhibition on 23rd October 2023.

Professor Michael Hanna (UCL Queen Square Institute of Neurology) leads a global team to understand genetic architecture of Neuromuscular Diseases and address genetic data inequality: The MRC International Centre for Genomic Medicine in Neuromuscular Disease – ICGNMD Consortium

We're delighted to announce that Professor Machado (Professor of Rheumatology and Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology) has won the 2023 Michael Mason Award presented by the British Society for Rheumatology (BSR).

Congratulations to Professor Michael Hanna (Director, UCL Queen Square Institute of Neurology) who has received a prestigious NIHR Senior Investigator award.

It is safe and effective to vaccinate people with inflammatory or autoimmune rheumatic and musculoskeletal diseases such as arthritis and lupus, a study led by UCL Queen Square Institute of Neurology has found.

The fifty newly elected Fellows of the Academy of Medical Sciences (AMS) includes nine academics from UCL, in recognition of the incredible contributions they have made to medical science.

A new collaborative study, involving UCL Queen Square Institute of Neurology and University of Miami, identifies sorbitol dehydrogenase (SORD) deficiency as a slowly progressive hereditary motor axonopathy caused by a genetic defect in the second step of the polyol pathway

We are delighted to announce that Professor Michael Hanna (Director, UCL Queen Square Institute of Neurology) has been elected to the Academy of Medical Sciences Council

We are delighted to announce that Professor Fiona Watt CEO MRC launched the new £5m International Centre for Genomic Medicine in Neuromuscular Diseases in an event hosted by Lord Kakkar on 3rd April 2019

UCL and the All India Institute of Medical Sciences (AIIMS) have entered into a new partnership which will enable much closer research collaboration and will explore opportunities to increase academic and student exchange between the institutions.